Health Canada inspection
Regeneron Pharmaceuticals, Inc.: Health Canada inspection of Mar 22, 2024
Health Canada · GMP · rating C
Key facts
| Establishment | Regeneron Pharmaceuticals, Inc. |
|---|---|
| City | Rensselaer |
| Province | NY |
| Country | United States |
| Program | GMP |
| Start date | Mar 13, 2024 |
| End date | Mar 22, 2024 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.